Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle
International Journal of Molecular Sciences · 23.04.2025 · 26 (9) · 3982
DOI: 10.3390/ijms26093982 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2025. Verfasst von Liyuan Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China. Hauptthemen laut MEDLINE: Chikungunya virus, Antibodies, Neutralizing, Chikungunya Fever, Single-Domain Antibodies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The Chikungunya virus (CHIKV) is a priority endemic pathogen identified by the World Health Organization and its infection induces an acute febrile illness in humans that is often associated with arthritis and musculoskeletal pain. Therefore, specific vaccines and treatments are urgently needed to prevent or treat Chikungunya disease. Here, we identify a series of CHIKV-specific neutralizing nanobodies (Nbs) from an alpaca which exhibit distinct binding modes compared to those previously reported. Two representative anti-CHIKV Nbs, N033-Fc and N053-Fc, demonstrated significant antiviral activity in Ifnar−/− mice against lethal challenge. Further studies elucidated the functional mechanisms of N033-Fc and N053-Fc in blocking CHIKV infection at multiple stages of the viral life cycle. This study identifies multiple candidate Nbs that may be suitable for next-generation antibody therapies to combat CHIKV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
- Laboratory of Advanced Biotechnology, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311215, China.
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
ORCID-Profile: Zhengshan Chen, Jiangfan Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, L., Fu, G., Li, J., Chen, Z., Fu, L., Yu, C., Qiang, L., Li, J., Fang, T., Yuan, H., & Li, J. (2025). Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle. International Journal of Molecular Sciences, 26(9), 3982. https://doi.org/10.3390/ijms26093982
Vancouver
Song L, Fu G, Li J, Chen Z, Fu L, Yu C, et al. Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle. International Journal of Molecular Sciences. 2025;26(9):3982. doi:10.3390/ijms26093982
BibTeX
@article{Song2025,
author = {Song, Liyuan and Fu, Guangcheng and Li, Jie and Chen, Zhengshan and Fu, Ling and Yu, Changming and Qiang, Li and Li, Jiangfan and Fang, Ting and Yuan, Hongyu and Li, Jianmin},
title = {Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {3982},
doi = {10.3390/ijms26093982}
}
EUVIMED